Mutagenic Impacts of Carcinogenic Drugs; Handling Hazardous Medical Products Directives in the EU devteam on March 28, 2022 Post navigation Next: Next post: PPP Magazine: Identify Gaps to Achieving USP <800> Compliance presented by Patricia C. Kienle, RPh, MPA, BCSCP, FASHP